AKT1 and esophageal cancer: TRIM44 significantly enhances the proliferation, migration, and invasion of human esophageal cancer cells by participating in the AKT/mTOR signaling pathway and phosphorylation of its downstream target STAT3 (Xiong et al., 2018).